Alteration of EGF-receptor binding in human breast cancer cells by antineoplastic agents.
about
Inhibitory effects of combinations of HER-2/neu antibody and chemotherapeutic agents used for treatment of human breast cancersZD1839 (IRESSA): a selective EGFR-TK inhibitor.Effect of alpha-difluoromethyl-ornithine on the expression and function of the epidermal growth factor receptor in human breast epithelial cells in culture.Intracellular calcium changes and chemosensitivities of human epidermoid carcinoma cell lines after exposure to cisplatin.
P2860
Alteration of EGF-receptor binding in human breast cancer cells by antineoplastic agents.
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年学术文章
@wuu
1987年学术文章
@zh
1987年学术文章
@zh-cn
1987年学术文章
@zh-hans
1987年学术文章
@zh-my
1987年学术文章
@zh-sg
1987年學術文章
@yue
1987年學術文章
@zh-hant
name
Alteration of EGF-receptor binding in human breast cancer cells by antineoplastic agents.
@en
Alteration of EGF-receptor binding in human breast cancer cells by antineoplastic agents.
@nl
type
label
Alteration of EGF-receptor binding in human breast cancer cells by antineoplastic agents.
@en
Alteration of EGF-receptor binding in human breast cancer cells by antineoplastic agents.
@nl
prefLabel
Alteration of EGF-receptor binding in human breast cancer cells by antineoplastic agents.
@en
Alteration of EGF-receptor binding in human breast cancer cells by antineoplastic agents.
@nl
P2093
P1476
Alteration of EGF-receptor binding in human breast cancer cells by antineoplastic agents.
@en
P2093
Arteaga CL
Chamness GC
Forseth BJ
Hanauske AR
Osborne CK
Von Hoff DD
P304
P356
10.1016/0277-5379(87)90318-X
P577
1987-05-01T00:00:00Z